|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
2553733 |
| 003 |
ICU |
| 005 |
20030522183900.0 |
| 008 |
970102s1996 dcua b 001 0 eng c |
| 010 |
|
|
|a 95021299
|
| 020 |
|
|
|a 0880484918
|
| 035 |
|
|
|a (ICU)BID22708785
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d DLC
|d OrLoB-B
|d OCoLC
|
| 041 |
0 |
|
|a eng
|
| 050 |
0 |
0 |
|a RC514
|b .N49 1996
|
| 060 |
|
0 |
|a W1 CL767J no.36 1996
|a WM 203 N531555 1996
|
| 082 |
0 |
0 |
|a 616.89/82061
|2 20
|
| 245 |
0 |
4 |
|a The new pharmacotherapy of schizophrenia /
|c edited by Alan Breier.
|
| 250 |
|
|
|a 1st ed.
|
| 260 |
|
|
|a Washington, DC :
|b American Psychiatric Press,
|c c1996.
|
| 300 |
|
|
|a xx, 240 p. :
|b ill. ;
|c 22 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 440 |
|
0 |
|a Clinical practice;
|v no. 36
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
0 |
|t Introduction to the Clinical Practice Series /
|r Judith H. Gold --
|t Foreword /
|r William T. Carpenter, Jr. --
|t Introduction and Overview /
|r Alan Breier --
|g 1.
|t Clozapine: Current Status and Clinical Applications /
|r Alan Breier and Robert W. Buchanan --
|g 2.
|t Risperidone: Clinical Applications /
|r Donna Ames, Stephen R. Marder and William C. Wirshing --
|g 3.
|t Future Antipsychotic Agents: Clinical Implications /
|r Anil K. Malhotra, Debra A. Pinsky and Alan Breier --
|g 4.
|t New Neuroleptics and Experimental Antipsychotics: Future Roles /
|r Adrienne C. Lahti, Robert A. Lahti and Carol A. Tamminga --
|g 5.
|t Conventional Neuroleptic Treatment: Current Status, Future Role /
|r John M. Kane --
|g 6.
|t Augmenting Antipsychotic Efficacy: New Approaches /
|r Laurence P. Karper and John H. Krystal --
|g 7.
|t Noradrenergic Systems: A Target for Augmenting Pharmacotherapy /
|r Robert E. Litman and David Pickar --
|g 8.
|t Benzodiazepines /
|r Owen M. Wolkowitz --
|g 9.
|t Treating Negative Symptoms: Pharmacological Strategies /
|r Robert W. Buchanan, Martin Brandes and Alan Breier --
|g 10.
|t Treatment of Depression in Patients With Schizophrenia /
|r Samuel G. Siris --
|t Conclusion /
|r Alan Breier.
|
| 650 |
|
0 |
|a Schizophrenia
|x Chemotherapy.
|0 http://id.loc.gov/authorities/subjects/sh85118163
|
| 650 |
|
0 |
|a Antipsychotic drugs.
|0 http://id.loc.gov/authorities/subjects/sh89002390
|
| 650 |
1 |
2 |
|a Schizophrenia
|x drug therapy.
|
| 650 |
|
7 |
|a Antipsychotic drugs.
|2 fast
|0 http://id.worldcat.org/fast/fst00810669
|
| 650 |
|
7 |
|a Schizophrenia
|x Chemotherapy.
|2 fast
|0 http://id.worldcat.org/fast/fst01106753
|
| 700 |
1 |
|
|a Breier, Alan,
|d 1953-
|0 http://id.loc.gov/authorities/names/n95801956
|1 http://viaf.org/viaf/14944867
|
| 901 |
|
|
|a ToCBNA
|
| 903 |
|
|
|a HeVa
|
| 903 |
|
|
|a Hathi
|
| 035 |
|
|
|a (OCoLC)32697809
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i daa6a08a-c321-5366-a662-677f87c89548
|s 3b1197b1-b66d-5413-bdce-ff6dc93b0b6b
|
| 928 |
|
|
|t Library of Congress classification
|a RC514.N490 1996
|l ASR
|c ASR-SciASR
|i 3002810
|
| 927 |
|
|
|t Library of Congress classification
|a RC514.N490 1996
|l ASR
|c ASR-SciASR
|e CRERAR
|b 44666251
|i 4734126
|
